Skip to main content
Log in

Toxicity of intravitreal oxiconazole

  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Oxiconazole, a new imidazole derivative, has a broad antifungal spectrum in vitro and in vivo. Adult New Zealand white rabbits were injected intravitreally with doses ranging from 10 to 100 micrograms of this drug. Eyes were evaluated with preoperative and postoperative biomicroscopy and indirect ophthalmoscopy, electroretinography, and light microscopy. From these data, it was determined that an intravitreal injection containing a concentration of up to 100 micrograms per 0.1 milliliter of oxiconazole was nontoxic to the rabbit eye.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gilbert CM, Novak MA. Successful treatment of post-operative Candida endophthalmitis in an eye with an intraocular lens implant. Am J Ophthalmol 1984; 97: 593–5.

    PubMed  Google Scholar 

  2. Pettit TH, Olson RJ, Foos RY, Martin WJ. Fungal endophthalmitis following intraocular lens implantation. A surgical epidemic. Arch Ophthalmol 1980; 98: 1025–39.

    PubMed  Google Scholar 

  3. Jones DB. Therapy of postsurgical fungal endophthalmitis. Trans Am Acad Ophthalmol Otolaryngol 1978; 85: 357–73.

    Google Scholar 

  4. Rowsey, JJ, Newsome DL, Sexton DJ, Harms WH. Endophthalmitis; current approaches. Ophthalmology 1982; 89: 1055–65.

    PubMed  Google Scholar 

  5. O'Day DM, Head WS, Robinson RD et al. Intraocular penetration of systemically administered antifungal agents. Current Eye Res 1985; 4: 131–4.

    Google Scholar 

  6. Silverman CA, Yoshizumi MO. Ocular toxicity of experimental intravitreal DMSO. J Toxicol Cutan Ocular Toxicol 1983; 2: 193–200.

    Google Scholar 

  7. Salmon JF, Partridge BM, Spalton DJ. Candida endophthalmitis in a heroin addict: A case report. Br J Ophthalmol 1983; 67: 306–309.

    PubMed  Google Scholar 

  8. Gebhart RJ, Espinel-Ingroff A, Shadomy S. In vitro susceptibility studies with oxiconazole (RO 13-8996). Chemotherapy 1984; 32: 244–7.

    Google Scholar 

  9. Polak. Oxiconazole, a new imidazole derivative. Drug Res 1982; 32: 17–24.

    Google Scholar 

  10. Polak A. Antifungal activity of four antifungal drugs in the cutaneous retention time test. Sabouraudia 1984; 22: 501–3.

    PubMed  Google Scholar 

  11. Odds FC, Webster CE, Abbott AB. Antifungal relative inhibition factors: Bay 1-9139, bifonazole, butoconazole, isoconazole, itraconazole (R51211), oxiconazole, RO14-4767/002, sulconazole, terconazole and vibunazole (Bay N-7133) compared in vitro with nine established antifungal agents. Antimicrob Agents Chemother 1984; 14: 105–14.

    Google Scholar 

  12. Plempel M, Berg D, Büchel KH, Abbin KD. Test methods for antifungal agents — a critical review. Mykosen 1987; 30: 28–37.

    PubMed  Google Scholar 

  13. Maurice DM. Injection of drugs into the vitreous body. In: Leopold IH, Burns RP, eds. Symposium on ocular therapy, Vol. 9. New York: Wiley, 1976: 59–72.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schulman, J.A., Peyman, G.A., Dietlein, J. et al. Toxicity of intravitreal oxiconazole. Int Ophthalmol 13, 201–203 (1989). https://doi.org/10.1007/BF02028210

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02028210

Key words

Navigation